ADVERTISEMENT
Podcasts
Refocusing the Multiple Sclerosis Treatment Landscape
09/16/2020
Edmund Pezalla, MD, MPH, CEO, Enlightenment Bioconsult LLC, discusses treatment options for multiple sclerosis, highlights results from the ASCLEPIOS I and II studies, and notes why this data can be useful for payers.
Reference: Hauser SL, Bar-Or A, Cohen JA, et al. Ofatumumab versus Teriflunomide in Multiple Sclerosis. N Engl J Med. 2020;383(6):546-557. doi:10.1056/NEJMoa1917246
Advertisement
Advertisement
Advertisement
Current Issue
September 2024
Volume 21
Issue 3
Advertisement
Advertisement
What's Trending?
Subscribe to our eNewsletters!
First Report Managed Care Newsletter